These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11164177)

  • 1. Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors.
    Terzolo M; Boccuzzi A; Bovio S; Cappia S; De Giuli P; Alì A; Paccotti P; Porpiglia F; Fontana D; Angeli A
    Urology; 2001 Jan; 57(1):176-82. PubMed ID: 11164177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indicators of malignancy of canine adrenocortical tumors: histopathology and proliferation index.
    Labelle P; Kyles AE; Farver TB; De Cock HE
    Vet Pathol; 2004 Sep; 41(5):490-7. PubMed ID: 15347821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
    Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S
    Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas.
    Iino K; Sasano H; Yabuki N; Oki Y; Kikuchi A; Yoshimi T; Nagura H
    Mod Pathol; 1997 Sep; 10(9):901-7. PubMed ID: 9310953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978).
    Bertagna C; Orth DN
    Am J Med; 1981 Nov; 71(5):855-75. PubMed ID: 6272575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between flow cytometric DNA ploidy and nuclear grade with endocrine dysfunction in adrenal cortical adenomas.
    Shono T; Sakai H; Irie J; Kawai K; Kanetake H; Saito Y
    Urology; 2000 Aug; 56(2):337-41. PubMed ID: 10925119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
    Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
    Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and immunoexpression of p53, MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms.
    Martins AC; Cologna AJ; Tucci S; Suaid HJ; Falconi RA
    J Urol; 2005 Jun; 173(6):2138-42. PubMed ID: 15879867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing cortical adrenal gland adenomas from carcinomas by their quantitative nuclear features.
    Scarpelli M; Montironi R; Mazzucchelli R; Thompson D; Bartels PH
    Anal Quant Cytol Histol; 1999 Apr; 21(2):131-8. PubMed ID: 10560481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical analysis of 103 cases of adrenal incidentaloma].
    Tao H; Lu ZL; Li HZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):172-5. PubMed ID: 12905714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical differential diagnosis of adrenocortical neoplasms using the monoclonal antibody D11.
    Schröder S; Niendorf A; Achilles E; Dietel M; Padberg BC; Beisiegel U; Dralle H; Bressel M; Klöppel G
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(2):89-96. PubMed ID: 2114700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
    Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z
    Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discerning malignancy in adrenocortical tumors: are molecular markers useful?
    Wachenfeld C; Beuschlein F; Zwermann O; Mora P; Fassnacht M; Allolio B; Reincke M
    Eur J Endocrinol; 2001 Sep; 145(3):335-41. PubMed ID: 11517015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry.
    Takehara K; Sakai H; Shono T; Irie J; Kanetake H
    Int J Urol; 2005 Feb; 12(2):121-7. PubMed ID: 15733104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential diagnosis of space-occupying adrenal masses].
    Szolar DH; Unger B; Heinz-Peer G; Preidler K; Ranner G
    Rofo; 1999 Oct; 171(4):269-78. PubMed ID: 10598161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minichromosome Maintenance Proteins MCM-3, MCM-5, MCM-7, and Ki-67 as Proliferative Markers in Adrenocortical Tumors.
    Aporowicz M; Czopnik P; Kubicka E; Piotrowska A; Dziegiel P; Bolanowski M; Domoslawski P
    Anticancer Res; 2019 Mar; 39(3):1151-1159. PubMed ID: 30842144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adrenal cortex tumors in children].
    Modrzejewska B; Blaim A; Marciński A; Truskolaska M
    Wiad Lek; 1984 Jun; 37(12):911-7. PubMed ID: 6523865
    [No Abstract]   [Full Text] [Related]  

  • 18. Cushing syndrome and adrenocortical carcinoma in a patient with CD4+ lymphocytopenia.
    Lewis SF; Vogelman BS; Graziano FM
    J Am Board Fam Pract; 2000; 13(3):219-21. PubMed ID: 10826873
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of histological and immunohistochemical patterns of benign and malignant adrenocortical tumors by computerized morphometry.
    Dalino Ciaramella P; Vertemati M; Petrella D; Bonacina E; Grossrubatscher E; Duregon E; Volante M; Papotti M; Loli P
    Pathol Res Pract; 2017 Jul; 213(7):815-823. PubMed ID: 28554744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endocrine hypertension].
    Lehnert H; Scholz T; Schäfer M; Klose S
    Dtsch Med Wochenschr; 2007 Feb; 132(5):207-17; quiz 219-20. PubMed ID: 17252364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.